Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.

Loganadane G, Kann BH, Park HS, Johnson SB, Mehra S, Judson BL, Bhatia A, Belkacemi Y, Yarbrough WG, Burtness B, Husain ZA.

Anticancer Res. 2019 Sep;39(9):4885-4890. doi: 10.21873/anticanres.13674.

PMID:
31519591
2.

Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins.

Benchetrit L, Torabi SJ, Morse E, Mehra S, Rahmati R, Osborn HA, Judson BL.

Laryngoscope. 2019 Aug 14. doi: 10.1002/lary.28224. [Epub ahead of print]

PMID:
31411749
3.

Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma.

Torabi SJ, Benchetrit L, Kuo Yu P, Cheraghlou S, Savoca EL, Tate JP, Judson BL.

JAMA Otolaryngol Head Neck Surg. 2019 Jun 13. doi: 10.1001/jamaoto.2019.1187. [Epub ahead of print]

PMID:
31194229
4.

Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment.

Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL.

Oral Oncol. 2019 Jul;94:32-40. doi: 10.1016/j.oraloncology.2019.05.009. Epub 2019 May 14.

PMID:
31178210
5.

Positive Surgical Margins in Submandibular Malignancies: Facility and Practice Variation.

Benchetrit L, Morse E, Judson BL, Mehra S.

Otolaryngol Head Neck Surg. 2019 Oct;161(4):620-628. doi: 10.1177/0194599819852094. Epub 2019 Jun 4.

PMID:
31159649
6.

Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands.

Cheraghlou S, Yu PK, Otremba MD, Mehra S, Yarbrough WG, Judson BL.

Cancers Head Neck. 2018 Jul 3;3:5. doi: 10.1186/s41199-018-0032-x. eCollection 2018.

7.

Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas.

Li H, Park HS, Osborn HA, Judson BL.

Cancers Head Neck. 2018 Jun 20;3:4. doi: 10.1186/s41199-018-0031-y. eCollection 2018.

8.

Clinically node-negative head and neck mucosal melanoma: An analysis of current treatment guidelines & outcomes.

Torabi SJ, Benchetrit L, Spock T, Cheraghlou S, Judson BL.

Oral Oncol. 2019 May;92:67-76. doi: 10.1016/j.oraloncology.2019.03.017. Epub 2019 Mar 28.

PMID:
31010627
9.

Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.

Lee NCJ, Kelly JR, An Y, Park HS, Judson BL, Burtness BA, Husain ZA.

Cancer. 2019 Jun 15;125(12):2018-2026. doi: 10.1002/cncr.32001. Epub 2019 Feb 12.

PMID:
30748002
10.

Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery.

Torabi SJ, Cheraghlou S, Kasle DA, Savoca EL, Judson BL.

Laryngoscope. 2019 Nov;129(11):2496-2505. doi: 10.1002/lary.27785. Epub 2019 Jan 10.

PMID:
30632157
11.

Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.

Li H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL.

Laryngoscope. 2019 Aug;129(8):1844-1855. doi: 10.1002/lary.27740. Epub 2018 Dec 21.

PMID:
30575965
12.

Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary Sinus.

Kuo P, Torabi SJ, Kraus D, Judson BL.

Otolaryngol Head Neck Surg. 2019 Apr;160(4):658-663. doi: 10.1177/0194599818804777. Epub 2018 Oct 9.

PMID:
30296902
13.

Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.

Lee NCJ, Kelly JR, Park HS, An Y, Judson BL, Burtness BA, Husain ZA.

Oral Oncol. 2018 Oct;85:35-39. doi: 10.1016/j.oraloncology.2018.08.001. Epub 2018 Aug 20.

PMID:
30220317
14.

Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014.

Cheraghlou S, Schettino A, Zogg CK, Judson BL.

Laryngoscope. 2018 Dec;128(12):2762-2769. doi: 10.1002/lary.27315. Epub 2018 Sep 7.

PMID:
30194691
15.

Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.

Cheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL.

Laryngoscope. 2019 Apr;129(4):883-889. doi: 10.1002/lary.27444. Epub 2018 Aug 27.

PMID:
30151947
16.

HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes.

Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL.

Laryngoscope. 2019 Mar;129(3):684-691. doi: 10.1002/lary.27475. Epub 2018 Aug 27.

PMID:
30151832
17.

Association of Facility and System Factors With Survival Among Pediatric Patients With Surgically Treated Head and Neck Sarcomas.

Cheraghlou S, Li H, Judson BL.

JAMA Otolaryngol Head Neck Surg. 2018 May 1;144(5):455-456. doi: 10.1001/jamaoto.2018.0183. No abstract available.

18.

Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database.

Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, Yarbrough WG, Burtness BA, Judson BL.

Head Neck. 2018 Jul;40(7):1343-1355. doi: 10.1002/hed.24984. Epub 2018 May 13.

PMID:
29756412
19.

Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.

Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z.

Oral Oncol. 2018 Apr;79:64-70. doi: 10.1016/j.oraloncology.2018.02.017. Epub 2018 Mar 8.

PMID:
29598952
20.

Lymph Node Yield as Quality Metric for Clinically N0 Oral Cancer.

Judson BL.

JAMA Otolaryngol Head Neck Surg. 2018 Apr 1;144(4):386. doi: 10.1001/jamaoto.2017.3333. No abstract available.

PMID:
29494723
21.

Prognostic Value of Lymph Node Yield and Density in Head and Neck Malignancies.

Cheraghlou S, Otremba M, Kuo Yu P, Agogo GO, Hersey D, Judson BL.

Otolaryngol Head Neck Surg. 2018 Jun;158(6):1016-1023. doi: 10.1177/0194599818756830. Epub 2018 Feb 20.

PMID:
29460685
22.

Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery.

Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL.

Otolaryngol Head Neck Surg. 2018 Mar;158(3):497-504. doi: 10.1177/0194599817742596. Epub 2018 Jan 2.

PMID:
29292665
23.

The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.

Schutt CA, Mirandola L, Figueroa JA, Nguyen DD, Cordero J, Bumm K, Judson BL, Chiriva-Internati M.

Oncotarget. 2017 Oct 31;8(59):100280-100287. doi: 10.18632/oncotarget.22213. eCollection 2017 Nov 21.

24.

Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.

Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL.

Cancer. 2018 Feb 15;124(4):717-726. doi: 10.1002/cncr.31104. Epub 2017 Dec 15.

25.

Leiomyosarcoma of the infratemporal fossa with perineurial spread along the right mandibular nerve: a case report.

Barbiero FJ, Huttner AJ, Judson BL, Baehring JM.

CNS Oncol. 2017 Oct;6(4):281-285. doi: 10.2217/cns-2017-0004. Epub 2017 Oct 9.

26.

Thirty-day morbidity and mortality following otologic/neurotologic surgery: Analysis of the national surgical quality improvement program.

Schwam ZG, Michaelides E, Kuo P, Hajek MA, Judson BL, Schutt C.

Laryngoscope. 2018 Jun;128(6):1431-1437. doi: 10.1002/lary.26848. Epub 2017 Sep 22.

PMID:
28940480
27.

Untreated oral cavity cancer: Long-term survival and factors associated with treatment refusal.

Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL.

Laryngoscope. 2018 Mar;128(3):664-669. doi: 10.1002/lary.26809. Epub 2017 Sep 2.

PMID:
28865100
28.

Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment.

Fujiwara RJT, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki CT, Yarbrough WG, Mehra S.

Oral Oncol. 2017 Aug;71:129-137. doi: 10.1016/j.oraloncology.2017.06.013. Epub 2017 Jun 23.

PMID:
28688680
29.

Comparing 30-Day Morbidity and Mortality in Pediatric and Adult Otologic Surgery.

Schwam ZG, Michaelides E, Schwam JR, Kuo P, Hajek MA, Judson BL, Schutt C.

Otolaryngol Head Neck Surg. 2017 Nov;157(5):830-836. doi: 10.1177/0194599817704376. Epub 2017 May 2.

PMID:
28463634
30.

Treatment delays in oral cavity squamous cell carcinoma and association with survival.

Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S.

Head Neck. 2017 Apr;39(4):639-646. doi: 10.1002/hed.24608. Epub 2017 Feb 25.

PMID:
28236349
31.

Radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base.

Cheraghlou S, Kuo P, Judson BL.

Cancer. 2016 Nov 15;122(21):3410. doi: 10.1002/cncr.30195. Epub 2016 Jul 15. No abstract available.

32.

Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.

Kuo P, Manes RP, Schwam ZG, Judson BL.

Otolaryngol Head Neck Surg. 2017 Jan;156(1):132-136. doi: 10.1177/0194599816670146. Epub 2016 Oct 5.

PMID:
27703092
33.

Treatment delay and facility case volume are associated with survival in early-stage glottic cancer.

Cheraghlou S, Kuo P, Judson BL.

Laryngoscope. 2017 Mar;127(3):616-622. doi: 10.1002/lary.26259. Epub 2016 Sep 22.

PMID:
27653749
34.

Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity.

Kuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL.

Cancer. 2016 Dec 1;122(23):3624-3631. doi: 10.1002/cncr.30227. Epub 2016 Aug 1.

35.

Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study.

Subramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA.

Cancers Head Neck. 2016 Jul 4;1:7. doi: 10.1186/s41199-016-0008-7. eCollection 2016.

36.

Reply to smoking cessation for patients with cancer: "The Emperor's New Clothes".

Ramaswamy AT, Toll B, Chagpar AB, Judson BL.

Cancer. 2016 Sep 15;122(18):2926. doi: 10.1002/cncr.30152. Epub 2016 Jun 10. No abstract available.

37.

Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.

Kuo P, Sosa JA, Burtness BA, Husain ZA, Mehra S, Roman SA, Yarbrough WG, Judson BL.

Cancer. 2016 Jun 15;122(12):1853-60. doi: 10.1002/cncr.29962. Epub 2016 Mar 28.

38.

Smoking, cessation, and cessation counseling in patients with cancer: A population-based analysis.

Ramaswamy AT, Toll BA, Chagpar AB, Judson BL.

Cancer. 2016 Apr 15;122(8):1247-53. doi: 10.1002/cncr.29851. Epub 2016 Feb 16.

39.

Receipt of Care Discordant with Practice Guidelines is Associated with Compromised Overall Survival in Nasopharyngeal Carcinoma.

Schwam ZG, Sosa JA, Roman S, Judson BL.

Clin Oncol (R Coll Radiol). 2016 Jun;28(6):402-9. doi: 10.1016/j.clon.2016.01.010. Epub 2016 Feb 8.

PMID:
26868285
40.

Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.

Blumberg J, Monjane L, Prasad M, Carrilho C, Judson BL.

Cancer Epidemiol. 2015 Dec;39(6):1000-5. doi: 10.1016/j.canep.2015.10.015. Epub 2015 Nov 18.

41.

Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998-2006.

Schwam ZG, Judson BL.

Oral Oncol. 2016 Jan;52:45-51. doi: 10.1016/j.oraloncology.2015.10.012. Epub 2015 Nov 6.

PMID:
26553389
42.

Vascular malformation with phleboliths involving the parotid gland: A case report with a review of the literature.

Ho C, Judson BL, Prasad ML.

Ear Nose Throat J. 2015 Oct-Nov;94(10-11):E1-5. Review.

PMID:
26535823
43.

Refusal of postoperative radiotherapy and its association with survival in head and neck cancer.

Schwam ZG, Husain Z, Judson BL.

Radiother Oncol. 2015 Nov;117(2):343-50. doi: 10.1016/j.radonc.2015.10.013. Epub 2015 Oct 24.

PMID:
26508285
44.

National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database.

Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL.

Cancer Med. 2015 Dec;4(12):1828-35. doi: 10.1002/cam4.546. Epub 2015 Oct 16.

45.

Severe epistaxis due to aberrant vasculature in a patient with STAT-1 mutation.

Chang MT, Schwam ZG, Hajek MA, Paskhover B, Judson BL.

Head Neck. 2016 Mar;38(3):E68-70. doi: 10.1002/hed.24165. Epub 2015 Oct 7.

PMID:
26445901
46.

Predictors of Survival in Sinonasal Adenocarcinoma.

Chen MM, Roman SA, Sosa JA, Judson BL.

J Neurol Surg B Skull Base. 2015 Jun;76(3):208-13. doi: 10.1055/s-0034-1543995. Epub 2015 Jan 5.

47.

Complications and mortality following surgery for oral cavity cancer: analysis of 408 cases.

Schwam ZG, Sosa JA, Roman S, Judson BL.

Laryngoscope. 2015 Aug;125(8):1869-73. doi: 10.1002/lary.25328. Epub 2015 Jun 9.

PMID:
26063059
48.

Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.

Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL.

JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):593-8. doi: 10.1001/jamaoto.2015.0719.

PMID:
25974757
49.

Intraoperative Vagus Nerve Monitoring: A Transnasal Technique during Skull Base Surgery.

Schutt CA, Paskhover B, Judson BL.

J Neurol Surg B Skull Base. 2015 Mar;76(2):87-9. doi: 10.1055/s-0034-1390404. Epub 2014 Sep 29.

50.

Hospital readmission and 30-day mortality after surgery for oral cavity cancer: Analysis of 21,681 cases.

Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL.

Head Neck. 2016 Apr;38 Suppl 1:E221-6. doi: 10.1002/hed.23973. Epub 2015 Sep 9.

PMID:
25537226

Supplemental Content

Loading ...
Support Center